BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20813740)

  • 41. Sebaceous carcinoma of the eyelid with metastasis to the parotid region: diagnosis by fine needle aspiration cytology.
    Mandreker S; Pinto RW; Usgaonkar U
    Acta Cytol; 1997; 41(5):1636-7. PubMed ID: 9305401
    [No Abstract]   [Full Text] [Related]  

  • 42. Sebaceous carcinoma of the eyelids: a review of 21 cases.
    Saito A; Tsutsumida A; Furukawa H; Saito N; Yamamoto Y
    J Plast Reconstr Aesthet Surg; 2008 Nov; 61(11):1328-31. PubMed ID: 17974515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Malignant eyelid tumours in Taiwan.
    Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
    Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
    Chen WS; Chen PL; Li J; Lind AC; Lu D
    J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fine needle aspiration cytology of eyelid tumors.
    Arora R; Rewari R; Betheria SM
    Acta Cytol; 1990; 34(2):227-32. PubMed ID: 2321455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Sebaceous gland adenoma of the eyelid].
    Shlopova NB; Shlopov VG
    Vestn Oftalmol; 1989; 105(5):76-8. PubMed ID: 2595908
    [No Abstract]   [Full Text] [Related]  

  • 47. Aberrant expression of beta- and gamma-catenin is an independent prognostic marker in oral squamous cell carcinoma.
    Ueda G; Sunakawa H; Nakamori K; Shinya T; Tsuhako W; Tamura Y; Kosugi T; Sato N; Ogi K; Hiratsuka H
    Int J Oral Maxillofac Surg; 2006 Apr; 35(4):356-61. PubMed ID: 16288849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Malignant tumor of the eyelid--clinical survey during 22-year period.
    Abe M; Ohnishi Y; Hara Y; Shinoda Y; Jingu K
    Jpn J Ophthalmol; 1983; 27(1):175-84. PubMed ID: 6855011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Eyelid sebaceous gland carcinoma (SGC) treated with 'slow' Mohs' micrographic surgery.
    Arora A; Barlow RJ; Williamson JM; Olver JM
    Eye (Lond); 2004 Aug; 18(8):854-5. PubMed ID: 14976544
    [No Abstract]   [Full Text] [Related]  

  • 50. Sebaceous gland carcinoma of the eyelids in Hawaii.
    Parsa FD
    Hawaii Med J; 1989 May; 48(5):165-6, 168. PubMed ID: 2753694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microscopic features and biologic behavior of eyelid tumors.
    McCord CD; Cavanagh HD
    Ophthalmic Surg; 1980 Oct; 11(10):671-81. PubMed ID: 7005795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sebaceous carcinoma of the ocular region: a review.
    Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
    Surv Ophthalmol; 2005; 50(2):103-22. PubMed ID: 15749305
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sebaceous adenocarcinoma of the eyelid.
    Neetens A; Bultink J; Hofkens R
    Bull Soc Belge Ophtalmol; 1978; 182():1-6. PubMed ID: 756324
    [No Abstract]   [Full Text] [Related]  

  • 54. [A case of Torre's syndrome: association of a meibomian adenocarcinoma with a cecal tumor].
    Charpentier P; Bloch-Michel E; Caillou B; Soussaline M; Boudier V; Offret H
    J Fr Ophtalmol; 1985; 8(6-7):479-85. PubMed ID: 4078227
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics and behavior of eyelid carcinoma (basal cell, squamous cell sebaceous gland, and malignant melanoma).
    Loeffler M; Hornblass A
    Ophthalmic Surg; 1990 Jul; 21(7):513-8. PubMed ID: 2204856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sebaceous carcinoma of eyelid presenting as dry-eye-syndrome (author's transl)].
    Henriquez AS; Arruga A
    Klin Monbl Augenheilkd; 1979 Sep; 175(3):318-21. PubMed ID: 529739
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
    Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
    Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of novel target proteins in sebaceous gland carcinoma.
    Erovic BM; Al Habeeb A; Harris L; Goldstein DP; Kim D; Ghazarian D; Irish JC
    Head Neck; 2013 May; 35(5):642-8. PubMed ID: 22715107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Eyelid skin adenoid cystic carcinoma: a clinicopathological study of one case simulating sebaceous gland carcinoma.
    Marback EF; Costa AL; Nossa LM; Marback RL; Rao NA
    Br J Ophthalmol; 2003 Jan; 87(1):118-9. PubMed ID: 12488275
    [No Abstract]   [Full Text] [Related]  

  • 60. Eyelid sebaceous carcinoma in situ presenting as haemorrhagic cyst.
    Wu A; Sun MT; Otto S; Huilgol SC; Selva D
    Australas J Dermatol; 2018 Nov; 59(4):e310-e311. PubMed ID: 29797387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.